Cohance ADC Play: Strong Growth Outlook

  Published 10 months ago

Broker cites Cohance’s strong ADC pipeline and growth levers, forecasting robust sales and EBITDA expansion.

  • Integrated ADC services and cross‑selling boost Cohance’s market position amidst easing specialty chemicals destocking pressures
  • Recovery expected by FY26, supporting projected 20% sales CAGR and 26% EBITDA CAGR through FY28
  • Cohance, formed from the Suven merger, offers global CRDMO capabilities targeting innovative pharmaceutical collaborations and growth

You might like these

JSW Steel Q1 Output Mixed

Lloyds Metals Shares Surge on New Plant & Pipeline

Ashok Leyland Reports Strong Q4 & FY25 Results

Kajaria Q2 FY26 Results: Revenue Up, Margins Rise

Ola Electric Secures PLI Boost, Profit Gains

India's 2025 Economic Outlook: Rate Cuts & Global Uncertainties

India Slams US Tariffs on Russian Oil Trade

News that matters the most ⚡